53.80 0.00 (0.00%)
After hours: 5:16PM EST
|Bid||53.26 x 800|
|Ask||54.19 x 800|
|Day's range||53.15 - 54.08|
|52-week range||41.03 - 56.88|
|Beta (5Y monthly)||1.32|
|PE ratio (TTM)||N/A|
|Earnings date||05 Feb 2020|
|Forward dividend & yield||1.92 (3.58%)|
|Ex-dividend date||30 Dec 2019|
|1y target est||51.80|
NEW YORK, Jan. 23, 2020 -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Cardinal Health,.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Cardinal Health, Inc. (NYSE: CAH) breached their fiduciary duties. Cardinal Health operates as an integrated healthcare services and products company.
Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.
Cardinal (CAH) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Surmodics (SRDX) is gaining from continued strength at Medical Devices unit and persistent efforts to boost R&D functionalities. However, weak performance at Surmodics' IVD unit remains a concern.
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, margin contraction remains a concern.
SAN DIEGO, Dec. 17, 2019 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Cardinal Health, Inc. (NYSE: CAH) shares. Investors,.
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).